Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after bacillus Calmette-Guerin treatment

By Ick K.   Schultz M.   Stout P.   Fan K.  

Urology, Vol. 49, Iss. 4, 1997-04 ,pp. : 541-547

Elsevier

Access to resources Recommend Favorite

Additional bacillus Calmette-Guerin therapy for recurrent transitional cell carcinoma after an initial complete response

By Bui T.T.   Schellhammer P.F.  

Urology, Vol. 49, Iss. 5, 1997-05 ,pp. : 687-691

Elsevier

Access to resources Recommend Favorite

Definitive tumor resection and percutaneous bacille Calmette-Guerin for management of renal pelvic transitional cell carcinoma in solitary kidneys

By Vasavada S.P.   Streem S.B.   Novick A.C.  

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 381-386

Elsevier

Access to resources Recommend Favorite

Intravesical bacillus Calmette-Guerin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder - 15 years outcome

By Baniel J.   Grauss D.   Engelstein D.   Sella A.  

Urology, Vol. 52, Iss. 5, 1998-11 ,pp. : 785-789

Elsevier

Access to resources Recommend Favorite

Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen

By Liedberg Fredrik   Anderson Harald   Bläckberg Mats   Chebil Gunilla   Davidsson Thomas   Gudjonsson Sigurdur   Jahnson Staffan   Olsson Hans   Månsson Wiking  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 4, 2007-09 ,pp. : 290-296

Informa Healthcare

Access to resources Recommend Favorite